Evaluation of Anti-Hyperglycaemic Activity of Polyherbal Formulation by using In-Vitro Methods

 

I. Srivallika1*, P. Shivasri1, M. Ramesh1, P. Jony Basha1, T. Vinay Kumar2,  B. Ram Sarath Kumar3, D. Rajesh Kumar4

1St.Mary’s College of Pharmacy, Chebrolu, Guntur(DT) Andhra Pradesh

2HOD, St. Mary’s College of Pharmacy, Chebrolu, Guntur (DT) Andhra Pradesh

3SIMS College of Pharmacy, Guntur Andhra Pradesh

4Dept. of Pharmacology, Siddhartha Institute of Pharmaceutical Sciences, Narsaraopet, Guntur (DT) Andhra Pradesh

*Corresponding Author E-mail:

 

ABSTRACT:

Diabetes mellitus is a chronic disorder caused by partial or complete insulin deficiency, resulting in hyperglycaemia leading to acute and chronic complications. The incidence of diabetes mellitus is on rise all over the world. Synthetic drugs are likely to give serious side effects in addition they are not suitable for intake during conditions like pregnancy. Hence, search for a new drug with low cost, more potential, without adverse effects is being pursued in several laboratories all around the world. Different extracts of Coriander, Cinnamon and Musa paradisiaca were used for determining antidiabetic activity. . In vitro antidiabetic activity was performed by Glucose Diffusion Inhibitory Study. The results showed  coriander and cinnamon reported anti-hyperglycemic effects and  use of floral extract of banana tree leads to correction of no. of secondary complications

     

KEYWORDS: Diabetes mellitus, hyperglycaemia, Coriander, Cinnamon and Musa paradisiaca.

 

 


INTRODUCTION:

DIABETES:

Diabetes mellitus, or simply diabetes, is a group of metabolic diseases in which a person has high blood sugar, either because the pancreas does not produce enough insulin, or because cells do not respond to the insulin that is produced.

 

Insulin produced by the pancreas lowers blood glucose. Absence or insufficient production of insulin causes diabetes.[1]

 

TYPES:

The two types of diabetes are referred to as type 1 and type 2. Former names for these conditions were insulin-dependent and non-insulin-dependent diabetes, or juvenile onset and adult onset diabetes.

 

Type 1 diabetes is also called insulin-dependent diabetes. It used to be called juvenile-onset diabetes, because it often begins in childhood. Type 1 diabetes is an autoimmune condition.

 

It's caused by the body attacking its own pancreas with antibodies. In people with type 1 diabetes, the damaged pancreas doesn't make insulin.

 

Type 2 DM results from insulin resistance, a condition in which cells fail to use insulin properly, sometimes combined with an absolute insulin deficiency. This form was previously referred to as non insulin-dependent diabetes mellitus (NIDDM) or "adult-onset diabetes".[4]

 

TABLE.1.COMPARISION OF TYPE 1 AND  TYPE 2 DIABETES

Feature

Type 1 diabetes

Type 2 diabetes

Onset

Sudden

Gradual

Age at onset

Mostly in children

Mostly in adults

Body habitus

Thin or normal

Often obese

Ketoacidosis

Common

Rare

Autoantibodies

Usually present

Absent

Endogenous insulin

Low or absent

Normal, decreased
or increased

Concordance
in identical twins

50%

90%

Prevalence

~10%

~90% [12,13]

SYMPTOMS:

Polyuria (frequent urination), polydipsia (increased thirst), and polyphagia (increased hunger).

 

DIAGNOSIS:

Diabetes is diagnosed by blood sugar (glucose) testing.

 

TABLE. 2. DIAGNOSIS OF DIABETES

Condition

2 hour glucose

mmol/l(mg/dl)

Fasting glucose

mmol/l(mg/dl)

HbA1c

%

Normal

<7.8 (<140)

<6.1 (<110)

<6.0

Impaired fasting glycaemia

<7.8 (<140)

≥ 6.1(≥110) & <7.0(<126)

6.0–6.4

Impaired glucose tolerance

≥7.8 (≥140)

<7.0 (<126)

6.0–6.4

Diabetes mellitus

≥11.1 (≥200)

≥7.0 (≥126)

≥6.5        [15]

 

CAUSES:

The cause of diabetes depends on the type.

Type 1 diabetes:

Type 1 diabetes is partly inherited, and then triggered by certain infections, with some evidence pointing at Coxsackie B4 virus. A genetic element in individual susceptibility to some of these triggers has been traced to particular HLA genotypes (i.e., the genetic "self" identifiers relied upon by the immune system). However, even in those who have inherited the susceptibility, type 1 DM seems to require an environmental trigger. The onset of type 1 diabetes is unrelated to lifestyle.[10,18]

 

Type 2 diabetes:

Type 2 diabetes is due primarily to lifestyle factors and genetics A number of lifestyle factors are known to be important to the development of type 2 diabetes, including obesity (defined by a body mass index of greater than thirty), lack of physical activity, poor diet, stress, and urbanization. Excess body fat is associated with 30% of cases in those of Chinese and Japanese descent, 60-80% of cases in those of European and African descent, and 100% of Pima Indians and Pacific Islanders. Those who are not obese often have a high waist–hip ratio. [7]

 

COMPLICATIONS:

The major complications of diabetes are both acute and chronic.

·        Acute complications: dangerously elevated blood sugar (hyperglycemia), diabetic ketoacidosis and nonketotic hyperosmolar coma.

·        Chronic complications: disease of the blood vessels (both small and large) which can damage the feet, eyes, kidneys, nerves, and heart may occur. [7,11]

 

TREATMENT:                                              

Diabetes treatment depends on the type and severity of the diabetes. Type 1 diabetes is treated with insulin, exercise, and a diabetic diet. Type 2 diabetes is first treated with weight reduction, a diabetic diet, and exercise[2]. When these measures fail to control the elevated blood sugars, oral medications are used. If oral medications are still insufficient, insulin medications and other injectable medications are considered. [9]

 

PLANT PROFILE:

Musa  paradisiaca:

Musa paradisiaca is the accepted name for the hybrid between Musa acuminata and Musa balbisiana belongs to family Musacae. Linnaeus originally used the name M. paradisiaca only for plantains or cooking bananas, but the modern usage includes hybrid cultivars used both for cooking and as dessert bananas. They are typically 2–9 meters (7–30 ft) tall when mature. The above-ground part of the plant is a "false stem" or pseudostem, consisting of leaves and their fused bases. [8,14]

 

Chemical constituents:

Tannins, eugenol, tyramine. High tannin content in the plant and unripe fruits has antibiotic activity. Serotonin, levarterenol, and dopamine are available in the ripe fruit and peel. Other chemical constituents are alkaloids, steroidal lactones, and iron [5]

 

CINNAMON:

Cinnamon is a spice obtained from the inner bark of several trees from the genus Cinnamomum that is used in both sweet and savoury foods. While Cinnamomum verum is sometimes considered to be "true cinnamon". All are members of the genus Cinnamomum in the family Lauraceae.

 

Chemical constituents:

C. verum bark yields 0.4–0.8% oil; tannins, consisting of polymeric 5,7,3′,4′-tetrahydroxyflavan-3,4-diol units; large amounts of catechins and proanthocyanidins (condensed tannins) and procyanidins; resins; mucilage; gum; sugars; calcium oxalate; two insecticidal compounds (cinnzelanin and cinnzelanol); coumarin (lowest concentration in Ceylon cinnamon); and others. C. verum cinnamon bark oil contains as its major component cinnamic aldehyde (usually 60–80%); other major constituents include sesquiterpenoids (4–5%) (e.g., α-humulene and β-caryophyllene that make up 3–4% of the total, limonene, and others), eugenol, eugenol acetate, cinnamyl acetate, cinnamyl alcohol, methyl eugenol, benzaldehyde, cuminaldehyde, benzyl benzoate, monoterpenes (e.g., linalool, pinene, phellandrene, and cymene), carophyllene, safrole, and others.

C. verum leaf oil contains high concentrations of eugenol (Ceylon type 80–88%; Seychelles type 87–96%); it also contains many of the major constituents present in cinnamon bark oil (e.g., benzyl benzoate (6%), cinnamaldehyde, cinnamyl acetate, eugenol acetate, benzaldehyde, linalool, α-terpinene, and others), as well as other minor compounds, including α-humulene, β-caryophyllene, α-ylangene, methyl cinnamate, and cinnamyl acetate.[6]

 

Coriandrum sativum:

Coriander (Coriandrum sativum), also known as cilantro, Chinese parsley or dhania, is an annual herb in the family Apiaceae.

 

Chemical constituents:

The essential oil from the coriander herb contained the highest amount of aliphatic aldehydes, among which was decanal, E-2-dodecanol and E-2-decenol had the highest percentages. In addition to the above-mentioned aliphatic aldehydes, the presence of linalool, phytol, and oleic acid was found in the essential oil extracted from the coriander herb.


 Fruits contain 0.2–2.6% (usually 0.4–1.0%) volatile oil. The major component of the oil is d-linalool (coriandrol), which is present in 55–74%, depending on the ripeness of the fruits, geographical locations, and other factors. Other compounds present in the oil include decyl aldehyde, trans-tridecene-(2)-al-(1), borneol, geraniol, geranyl acetate, camphor, carvone, anethole, caryophyllene oxide, elemol, and monoterpene hydrocarbons (mainly γ-terpinene, and α- and β-pinene, d-limonene, p-cymene, β-phellandrene, and camphene, with relative proportions varying considerably with sources). Other constituents present in fruits include up to 26% fats made up of glycerides (primarily of oleic, petroselinic and linolenic acids), a small amount of unsaponifiable matter (containing β-sitosterol, δ-sitosterol, triacontane, triacontanol, tricosanol, etc.), and Δ-octadecenoic acid; proteins (11–17%); about 1.0% starch and 20% sugars; coumarins (psoralen, angelicin, scopoletin, umbelliferone, etc.); flavonoid glycosides, including quercetin-3-glucuronide, isoquercitrin, coriandrinol (β-sitosterol-d-glucoside), and rutin; tannins; chlorogenic and caffeic acids; and others.

 

Leaves contain less volatile oil than fruits; about 5% fats; about 22% proteins; sugars; coumarins and flavonoid glycosides similar to those in fruits; chlorogenic and caffeic acids; vitamin C; and others. The volatile oil contains mainly decyl and nonyl aldehydes, and linalool, among others.

 

 

SCREENIG MODELS FOR DIABETIC MELLITUS:

TABLE.3.DIFFERENT MODELS FOR IDDM

Chemically induced

STZ (Streptozotocin)

 induced diabetes, Alloxan induced diabetes.

Other diabetogenic chemicals induce models

Dithizone induced diabetes .

Goldthioglucose induced diabetes.

Monosodium glutamate induced diabetes.

Hormones induced diabetes

Growth hormone induced diabetes

Corticosteroid induced diabetes

Virus induced diabetes

EMC-D or M variant Mengo-2T CB4 Reo Kilham rat virus

Insulin Antibodies-induce diabetes

        _____

Surgically induced diabetes

        _____

Genetic Models

The NOD mouse The  BB rat[16]

 

MATERIALS AND METHODS:

Preparation of extract:

The shade dried powdered material was subjected to successive extraction using n-hexane, Ethyl acetate, Ethanol by continuous percolation process in soxhlet apparatus. The aqueous extract was prepared by the maceration with water. Each extract was concentrated by distilling off the solvent and evaporated to dryness. The extracts were dissolved in 1% carboxy methyl cellulose (CMC) and used for the present study.

 

IN VITRO ANTIDIABETIC ACTIVITY (BY GLUCOSE DIFFUSION INHIBITORY STUDY):

A simple model system was used to evaluate the effects of plant extracts on glucose movement in vitro. The model was adapted from a method which involved the use of a sealed dialysis tube into which 15ml of a solution of glucose and sodium chloride (0.15M) was introduced and the appearance of glucose in the external solution was measured. The model used in the present experiment consisted of a dialysis tube (6cmX15mm) into which 1ml of 50g/liter plant extract in 1% CMC and 1ml of 0.15M sodium chloride containing 0.22M D-glucose was added. The dialysis tube was sealed at each end placed in a 50ml centrifuge tube containing 45ml of 0.15M sodium chloride. The tubes were placed on an orbital shaker and kept at room temperature. The movement of glucose into the external solution was monitored at set time intervals. Estimation of glucose was estimated by popular known GOD/POD method.

 

Preparation of diffusion tube:

A centrifuge tube was taken which is closed at one end; to this on another side the semi-permeable tube is attached. Egg membrane is taken for this purpose. Egg membrane is isolated by submerging it in Conc. Nitric acid.

 

Estimation of glucose:

Photometric estimation of glucose in plasma based on GOD/ POD method is done as described in the manufacturer’s (Aspen Pvt. Ltd.) instruction manual as follows:

 

Principle:

Glucose is oxidized by oxidase to gluconic acid and H2O2 is liberated. The colorimetric indicator, quioneimine is generated from 4-aminopyrine and phenol by H2O2 under the catalytic action of peroxidase. Intensity of color generated is directly proportional to glucose concentration.[17]

β-D-glucose + H2O + O2                Gluconic acid + H2O2

 

Assay:

Wavelength------ 500-540 nm

Temperature----- 370C

Light path-------- 1cm

 

 

Solutions

Blank

Sample\Standard

Sample\Standard

--

10µl

Distilled water

10µl

--

Reagent

1000 µl

1000 µl

 

Mix, incubate for approx. 15 min at 370C and read the absorbance against the blank within the 30 min.   

 

Calculation:

                                            Absorbance of Test

Glucose Concentration = -----------------------------x Concentration of

(mg/dl)                              Absorbance of Standard            Standard

                                            

 

Statistical Analysis:

Data are expressed as mean + S.E.M. Statistical comparison between groups were done by one way analysis of variance (ANOVA) followed by Tukey Kramer multiple comparison test to analyze the differences. p<0.001 were considered as significant.

 

RESULTS AND DISCUSSION:

Effects of various extracts on glucose diffusion:

The effect of various extracts on glucose diffusion inhibition was depicted in Fig 1 and table-4.

 

At the end of 27 hrs, glucose movement of control (without plant extract) in the external solution had reached a plateau with a mean glucose concentration above 300mg/dl (316.66+1.76). It was evident from the graph that the ethanol and aqueous extracts were found to be potent inhibitors of glucose diffusion (p<0.001) compared to control. The ethanol extract was found to be more potent than other extracts showing the lowest mean glucose concentration of 208+1.15 mg/dl at the end of 27 hrs. Thus the ethanol and aqueous extracts can be selected for further in vivo studies.

 

CONCLUSION:

The present study was carried out to estimate the efficiency of several plants which are used as spices in daily dishes. When we used these spices as different extracts they showed anti-hyperglycemic activity and it was done on the basis of their effectiveness of chemical constituents. The study was performed by using the diffusion tube method rather than using animals. Finally it is proven that ethanolic extract showed better potent than other extracts. So, it may be beneficial to use ethanolic extract than conventional anti-diabetics taking advantage of less side effect. Since ethanolic extract may interact metabolism of the drugs, it advised to go for aqueous extract than any type of extract.

 

FIG.1.Effect of Different Extracts on Diffusion of Glucose


 

Table.4. EFFECTS OF VARIOUS EXTRACTS ON GLUCOSE DIFFUSION:

Extract

1hr

3hr

5hr

24hr

27hr

Control

(in the absence of Extract)

145.66+1.20

201.33+1.76

244.33+1.76

312.33+2.02

316.66+1.76

n-hexane extract (50g/l)

105.33+1.20***

184+1.15***

216+1.15***

293+1.15***

303.33+1.20***

Ethyl acetate extract (50g/l)

94+1.15***

155.33+0.88***

193.66+0.88***

256.33+1.45***

262.33+0.88***

Ethanol extract (50g/l)

76.33+0.88***

105+1.73***

143.66+1.20***

203+1.52***

208+1.15***

Aqueous extract (50g/l)

83.33+0.88***

116.33+0.88***

157.33+1.20***

228.66+1.76***

232+2.18***

Values are expressed as mean + SEM n=3; Data were analysed using one way ANOVA followed by Tukey-Kramer multiple comparison test; ***p<0.001 compared to control.


 

SCOPE OF THE STUDY:

The aqueous and ethanolic extracts may be used for in-vivo study for determining their plasma glucose decreasing activity.

 

REFERENCES:

1.       Ahamed R. G. “The physiological and biochemical effects of diabetes on the balance between oxidative stress and antioxidant defense system”. Med. J. Islamic world Acad. Sci 2005; 15: 31-42.

2.       Amir Tirosh, Ruth Potashnik, Nava Bashan, and Assaf Rudich. “Oxidative Stress Distrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-kinase in 3T3-L1 Adipocytes”. The Journal of Biological Chemistry 1999; 274(15): 10595-10602.

3.       Ana Maria Cavalcanti, Cristiane Hatsuko Baggio, Cristina Setim Freitas, Lia Rieek Renato Silva de Sousa, Jose Eduardo Da Silva-Santos, Sonia Mesia-Vela and Mari Concuelo Andrade Marques. “Safety and antiulcer efficacy studies of Achillea millefolium L.after chronic treatment in Wistar rats”. Journal of Ethnopharmacology 2006; 107(2): 277-28.

4.       Anderson, J. R., In; Muir’s Textbook of Pathology, 11th Edn., ELBS and Arnold (publishers) Ltd., London, 1980, 1015.

5.       Arthur S. Goldberg, Evangelynne C. Mueller, Edward Eigen ,Salvatore J. Desalva. “Isolation of the anti-inflammatory principles from Musa paradisiaca (Zinzibarecea). Journal of Pharmaceutical Sciences 2006; 58(8):938-941.

6.       Ashok k Tiwari. “Wisdom of Ayurveda in perceiving diabetes: enigma of therapeutic recognition”. Current Science 2005; 88(7) 1043-1051.

7.       Ashok K. Tiwari, and J. Madhusudana Rao. “Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects”. Current Science 2002; 8.3(1): 30-38.

8.       B. Benedek, N. Geisz, W. Jager, T. Thalhammer and B. Kopp. “Choleretic effects of yarrow (Musa Paradisiaca s.1.) In the isolated perfused rat liver”.Phytomedicine 2006; 13(9-10): 702-706.

9.       Barar, F. S. K., In; Essential of Pharmacotherapeutics, 10th Edn., S. chand and company Ltd., New –Delhi,2005,340.

10.     Baynes J.W, S.R. Thorpe. “Role of oxidative stress in complications”. Curr. Opin. Endocrinol 1997; 3: 277-284.

11.     Baynes J.W. “Role of oxidative stress in development of complications of diabetes mellitus”. Diabetes 1991; 40: 405-412.

12.     Bennett, P. N., Brown, M. J., In; Clinicl Pharmacology, 9th Edn., Churchill livingstone international  edn., Spain, 2003, 680.

13.     Boyd, W. A., In; Textbook of Pathology Structure and Function in Disease, 8th Edn., Published in Great Britain by Herry Kimpton, London, 1979;915, 916.

14.     Chandler RF, Hooper SN, Hooper DL, Jamieson WD, Flinn CG, Safe LM. “Herbal remedies of Maritime Indiands; sterols and triterpenes of Musa Paradisiaca L. (Yarrow)”. J. Pharm Sci 1982; 71(6): 690-693.

15.     Cooper M: Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352:213-19.

16.     D. A. Rees and J. C. Aleolado. “Animal models of diabetes mellitus”. Diabetes Medicine 2005; 22: 359-370.

17.     Devasagayam TPA, Boloark K, Ramasarma T. “Methods for estimating lipid peroxidation : An estimation of merits and demerits”. Ind J Biochem Biophys2003; 40:300-308.

18.     Devasenan Devendra, Edvin Liu, George S. Eisenbarth. “Type 1 diabetes: recent developments”. British medical journal 2004; 328: 750-754

 

 


 

Received on 19.02.2014                             Modified on 01.03.2014

Accepted on 04.03.2014      ©A&V Publications All right reserved

Res. J. Pharmacology & P’dynamics. 6(1): Jan.-Mar. 2014; Page 36-40